High Resolution 3D Diffusion-weighted Breast MRI

Trial ID or NCT#

NCT01315106

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to determine how well a new MRI technique called "High resolution 3D diffusion-weighted breast MRI" detects breast cancer.

Official Title

High Resolution 3D Diffusion-weighted Breast MRI

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. 1. Patient scheduled for contrast-enhanced breast MRI to image possible breast cancer. 2. Female 3. Age >18
Exclusion Criteria:
  1. 1. Lactation 2. Pregnancy 3. Patient undergoing chemotherapy. These patients are excluded because chemotherapy changes the biology of breast cancers. Since the ultimate objective of the research is to develop a new imaging method for breast MRI screening (detection of previously unknown tumors), results in treated tumors would not be relevant. Including treated tumors could yield a misleading assessment of the performance of the new method since treated tumors have different imaging characteristics than de novo tumors. 4. Patient scheduled for pre-operative chemotherapy. These patients are excluded if they are going to be treated only on the basis of fine needle aspiration. The project seeks to correlate all tumors detected with standard histopathology of their untreated neoplasm. This exclusion criteria will be very unusual because most patients planning neoadjuvant chemotherapy do so on the basis of a pre-chemo core needle biopsy, which provide adequate histopathologic proof necessary for enrollment.
View All Criteria
Show Less

Investigator(s)

Bruce Daniel
Bruce Daniel
Radiologist
Professor of Radiology (Body Imaging) and, by courtesy, of Bioengineering
Brian A. Hargreaves

Contact us to find out if this trial is right for you.

Contact

Jocelyn Steffen
650-725-1812

View on ClinicalTrials.gov